Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA31925
Max Phase: Preclinical
Molecular Formula: C28H25NO9
Molecular Weight: 519.51
Molecule Type: Small molecule
Associated Items:
ID: ALA31925
Max Phase: Preclinical
Molecular Formula: C28H25NO9
Molecular Weight: 519.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc([C@@H]2c3cc4c(cc3[C@@H](Nc3ccc(C(=O)O)cc3)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
Standard InChI: InChI=1S/C28H25NO9/c1-34-21-7-14(8-22(35-2)26(21)30)23-16-9-19-20(38-12-37-19)10-17(16)25(18-11-36-28(33)24(18)23)29-15-5-3-13(4-6-15)27(31)32/h3-10,18,23-25,29-30H,11-12H2,1-2H3,(H,31,32)/t18-,23+,24-,25+/m0/s1
Standard InChI Key: CZXDFQJUHGPKOF-LVEBQJTPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 519.51 | Molecular Weight (Monoisotopic): 519.1529 | AlogP: 3.92 | #Rotatable Bonds: 6 |
Polar Surface Area: 132.78 | Molecular Species: ACID | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.73 | CX Basic pKa: 2.18 | CX LogP: 3.10 | CX LogD: 0.47 |
Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.41 | Np Likeness Score: 1.11 |
1. Cho SJ, Tropsha A, Suffness M, Cheng YC, Lee KH.. (1996) Antitumor agents. 163. Three-dimensional quantitative structure-activity relationship study of 4'-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach., 39 (7): [PMID:8691468] [10.1021/jm9503052] |
2. Zhang YL, Guo X, Cheng YC, Lee KH.. (1994) Antitumor agents. 148. Synthesis and biological evaluation of novel 4 beta-amino derivatives of etoposide with better pharmacological profiles., 37 (4): [PMID:8120864] [10.1021/jm00030a003] |
Source(1):